We are constantly looking for opportunities to exchange and develop ideas, as they are the foundation for scientific advances and innovation. In addition to our collaboration with academic and commercial partners, attending conferences such as Knowledge for Growth provides us with insights and connections that help us improve our current offerings.
InnoSer is eager to be present at this exciting event organized by Flanders Bio, where we will be happy to discuss our services aimed at accelerating preclinical research. Our Business Development Managers are looking forward to connecting with other life science enthusiasts both at the exhibition but also in meetings with swapcard.
InnoSer has a wide portfolio of in vivo and in vitro services which can be customized to your research project and specific needs. Our various methods can also be combined to improve the reliability and transferability of your data, which is especially important to avoid low success rates in drug development. Besides, Innoser offers not only reliable platforms for drug screening but also facility management services and support with scientific expertise. We are specialized in oncology, polycystic kidney disease, neurodegenerative diseases and cardio-metabolic diseases.
Support in drug development
Outside of our disease specific models and therapeutic expertise InnoSer can provide general contract research services to a range of therapeutic areas. With our fully equipped facilities we are capable of supporting tailored and customized options to support your project no matter your field of interest. Below is a selection of services that could support your research goals and milestones.
Pharmacology/efficacy studies and customized offerings
- Safety, tolerability and toxicology
- PK/PD studies
- Patient-derived xenografts and organoids
- 2D cell culture
- Disease model development
- Medical device testing
Providing high-quality readouts and facility management services
- 腫瘍の移植
- 契約繁殖
- 凍結保存
- Live cell imaging
- Bioluminescent imaging
- Ultrasound
- Flow cytometry
You can find an overview of our offerings at https://www.innoserlaboratories.com/services/ Interested in getting to know the full scope of our services that support drug development at Knowledge for Growth? We encourage you to book a meeting now using swapcard and get in touch with one of our Business Development Managers. See you soon!
Missed the event but still interested?
もっと読みたいですか?
STXBP1 Foundation and InnoSer validate R122X, a patient-variant mouse model of STXBP1 encephalopathy, to help expand therapeutic opportunities in STXBP1 research
Gene therapies, antisense oligonucleotides (ASOs), RNA editing technologies, and other precision medicine approaches are rapidly transforming the therapeutic landscape for STXBP1 encephalopathy. Currently, around 16 candidate therapies are in development across five...
Cognitive profiling in the APP[V717I]xTau[P301S] mouse model
In this month's update, we revisit the APP[V717I]xTau[P301S] model with newly in-house generated Morris Water Maze (MWM) data, reconfirming the spatial memory deficits previously described for this model and reinforcing the translational value of the model.The...
トランスレーショナルな意義を持つ非侵襲的な疾患進行指標としての総腎臓体積(TKV)
今月のニュースレターでは、ADPKDマウスモデルを用いたInnoSer社の非侵襲的超音波画像診断による腎臓総容積(TKV)の経時的な評価が、臨床現場に即した構造的指標を提供し、…における意思決定を直接的に支援する方法についてご紹介します。


![Cognitive profiling in the APP[V717I]xTau[P301S] mouse model](https://www.innoserlaboratories.com/wp-content/uploads/2026/07/Figure-1-MWM.png)
